Posts Tagged 'teva pharmaceuticals'

First Trial Scheduled in Opioid MDL

Judge Polster schedules opioid MDL for March 2019 startThe judge overseeing the MDL that seeks to hold drug manufacturers and distributors responsible for their roles in the nation’s ongoing opioid abuse epidemic has scheduled the first cases in the litigation for trial. If all goes to plan, some very serious questions might start seeing answers beginning in March of next year.

U.S. District Judge Daniel Polster had, to this point, sought to get ...

continue reading...

Teva Suspends Zecuity Sales

teva suspends sales of zecuityJust nine months after bringing Zecuity to market, Teva Pharmaceuticals has suspended all sales activity surrounding their new migraine relief patch. This includes marketing as well as distribution.

Zecuity’s launch has gone far worse than expected for Teva. The FDA issued a safety alert regarding the migraine relief patch earlier this month after a “large number of patients” experienced burns and scarring on the patch site.

Zecuity was intended to work by ...

continue reading...

Migraine Patch May Cause Severe Burns and Scarring

zecuity patch found to cause burns and scarringFor the 36 million Americans that suffer from migraines, any chance at relief is a chance worth considering – at the very least. The debilitating headaches can strike anywhere from 10 to 14 days a month for chronic suffers and the effects can be anything from extreme sensitivity to light to nausea and vomiting. Migraines are far more than just regular headaches.

Various prescription pain relievers are available to try ...

continue reading...

Androgel Manufacturer Drops Plan to Purchase Shire

First Word Pharma reports that Androgel maker AbbVie has abandoned its plan to buy out pharmaceutical maker Shire. AbbVie says the bid for Shire was withdrawn in light of recent U.S. tax law changes. As a result of the failed deal, AbbVie will have to pay $1.6 billion to Shire and will be unable to make another offer to purchase the company for at least a year.

The Androgel maker was recently in the news over allegations ...

continue reading...

Teva Announces Department of Justice Investigation Into Potential False Claims Act Violations

In an annual report filed with the Securities and Exchange Commission, Teva Pharmaceutical Industries announced that the Department of Justice subpoenaed information relating to two of the company’s drugs. Copaxone, a drug to treat multiple sclerosis, is Teva’s top-selling drug. It is an injectable drug that the FDA approved for reducing the frequency of relapses, although there are claims that it may also reduce the progression of the disability. Azilect is used for the treatment ...

continue reading...

Teva Pharmaceuticals Granted Exclusive Rights by FDA to Retail One-Step Plan B

According to a report from The Boston Globe, the US Food and Drug Administration (FDA) has granted Teva Pharmaceuticals the exclusive right to place its emergency contraception, One-Step Plan B, on the shelves of drugstores without any age restrictions. Exclusivity was granted for the next three years.

This was made possible when US District Judge Edward Korman of New York ordered in April, 2013 that all levonorgestrel-based emergency contraceptives be available over the counter without a prescription. Judge Korman’s ...

continue reading...